Midatech and MonoSol Rx Announce Positive Phase 1 Clinical Results for their Novel Transbuccal Oral Insulin Film Product

07-May-2012 - Midatech Ltd. and MonoSol Rx LLC announced positive bioavailability and pharmacokinetic results from a first-in-human Phase 1 clinical study of their Midaform™ Insulin PharmFilm product in 27 healthy volunteers. The companies have licensed to their joint venture company, MidaSol Therapeutics LLC, ...

MonoSol Rx and Midatech Ltd Complete Transbuccal Insulin Delivery Study in Primate Diabetes Model

11-Jan-2011 - MonoSol Rx and Midatech Group Ltd. announced positive results from a pre-clinical study of insulin PharmFilm, the first-ever oral insulin film formulation to transbuccally deliver an active therapeutic dose of insulin in a diet-induced diabetic primate model.The two companies are developing ...

Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems

18-Aug-2010 - Midatech Group Ltd. and MonoSol Rx announced the filing of a provisional US patent application for “Nanoparticle Film Delivery Systems.” The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides ...

Midatech Group and MonoSol Rx Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

Potential to Develop New Oral Drug Candidates with Superior Efficacy, Safety, Convenience, and Commercial Potential

10-Nov-2008 - Midatech Group and MonoSol Rx announced a partnership to develop new drug formulations combining biocompatible nanoparticles and PharmFilm delivery technologies. Under terms of the agreement, Midatech Ltd and MonoSol Rx will jointly research, develop and commercialize new drug candidates ...